AGM Chairmans Address and Investor Presentation
Filed with ASX · · 21 pages · English
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release a copy of the Chairman ’ s Address to be provided by Mr N eville Gardiner and the Investor Presentation to be provided by Dr Richard Lipscombe to shareholders at the Annual General Meeting to be held in Perth com mencing at 9:30 am AWST today. Authorised by Dr Richard Lipscombe (Managing Director)
Proteomics International Laboratories Ltd. on 6ix
In the deck
Story so far
Earlier from Proteomics International Laboratories
- PromarkerD patent granted in Hong Kong
- September 2022 Quarterly Activities Report and Appendix 4C
- Precision diagnostics facility receives $2m funding boost
- Proteomics receives $1.7 million in R&D tax incentive
- New Oesophageal Cancer Diagnostic shows strong performance
Later from Proteomics International Laboratories
- UK NICE publishes Medtech Innovation Briefing on PromarkerD
- CPT PLA reimbursement code approved in US for PromarkerD
- Letter of intent with Sonic Healthcare USA extended
- December 2022 Quarterly Activities Report and Appendix 4C
- Distribution agreement for PromarkerD in Britain extended
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories